CHANGES IN PULMONARY SURFACTANT DURING BACTERIAL PNEUMONIA

被引:33
作者
BROGDEN, KA
机构
[1] Respiratory Disease Research Unit, National Animal Disease Center, Agricultural Research Service, U.S. Department of Agriculture, Ames, 50010, IA
来源
ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY | 1991年 / 59卷 / 04期
关键词
BACTERIAL PNEUMONIA; ENDOTOXIN; LIPOPOLYSACCHARIDE; LUNG; PULMONARY SURFACTANT;
D O I
10.1007/BF00583673
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In pneumonia, bacteria induce changes in pulmonary surfactant. These changes are mediated by bacteria directly on secreted surfactant or indirectly through pulmonary type II epithelial cells. The bacterial component most likely responsible is endotoxin since gram-negative bacteria more often induce these changes than gram-positive bacteria. Also, endotoxin and gram-negative bacteria induce similar changes in surfactant. The interaction of bacteria or endotoxin with secreted surfactant results in changes in the physical (i.e. density and surface tension) properties of surfactant. In addition, gram-negative bacteria or endotoxin can injure type II epithelial cells causing them to produce abnormal quantities of surfactant, abnormal concentrations of phospholipids in surfactant, and abnormal compositions (i.e. type and saturation of fatty acids) of PC. The L/S ratio, the concentration of PG, and the amount of palmitic acid in PC are all significantly lower. The changes in surfactant have a deleterious effect on lung function characterized by significant decreases in total lung capacity, static compliance, diffusing capacity, and arterial PO2, and a significant increase in mean pulmonary arterial pressure. Also decreased concentrations of surfactant or an altered surfactant composition can result in the anatomic changes commonly seen in pneumonia such as pulmonary edema, hemorrhage, and atelectasis.
引用
收藏
页码:215 / 223
页数:9
相关论文
共 39 条
[1]   INCREASED SURFACE-TENSION FAVORS PULMONARY-EDEMA FORMATION IN ANESTHETIZED DOGS LUNGS [J].
ALBERT, RK ;
LAKSHMINARAYAN, S ;
HILDEBRANDT, J ;
KIRK, W ;
BUTLER, J .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 63 (05) :1015-1018
[2]  
ARACIL FM, 1985, MOL CELL BIOCHEM, V68, P59
[3]  
BARROW RE, 1979, J PHYSIOL-LONDON, V295, P217, DOI 10.1113/jphysiol.1979.sp012963
[4]  
BAUGHMAN RP, 1984, CLIN CHEM, V30, P521
[5]  
BOSCH MA, 1990, MOL CELL BIOCHEM, V93, P167
[6]   COMPLEXING OF BACTERIAL LIPOPOLYSACCHARIDE WITH LUNG SURFACTANT [J].
BROGDEN, KA ;
CUTLIP, RC ;
LEHMKUHL, HD .
INFECTION AND IMMUNITY, 1986, 52 (03) :644-649
[7]  
BROGDEN KA, 1986, AM J VET RES, V47, P727
[8]  
BROGDEN KA, 1989, AM J VET RES, V50, P555
[9]  
BROGDEN KA, 1986, 14 P INT C MICR MANC, P64
[10]  
CLEMENTS JA, 1965, RESPIRATION, P1565